NCT03062254 Metabolic Change in Prostate Cancer Bone Metastases on 68Ga-HBED-CC-PSMA PET/CT Following Radium-223 Therapy Status COMPLETED Phase PHASE2
NCT03061760 Effects of Urinary Bladder Hypertrophy on Urge Urine Incontinence After Radical Prostatectomy Status UNKNOWN Phase N/A
NCT03061539 Nivolumab and Ipilimumab Treatment in Prostate Cancer With an Immunogenic Signature Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03056638 Trial of ADT and SBRT Versus SBRT for Intermediate Prostate Cancer Status TERMINATED Phase PHASE3
NCT03050996 Retrograde Perfusion Sphinterometry and Autologous Sling to Improve Urinary Continence in Robotic Radical Prostatectomy Status UNKNOWN Phase N/A
NCT03044197 Detection of Clinically Significant Prostate Cancer Using Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy Status COMPLETED Phase NA
NCT03043989 Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, Clarithromycin Status TERMINATED Phase PHASE1
NCT03043807 A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy Status COMPLETED Phase PHASE2
NCT03042468 Phase I Dose-escalation Study of Fractionated 177Lu-PSMA-617 for Progressive Metastatic CRPC Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03040791 Nivolumab in Prostate Cancer With DNA Repair Defects (ImmunoProst Trial) Status UNKNOWN Phase PHASE2
NCT03035032 A Study of ELIGARD® in Hormone-dependent Prostate Cancer Patients Status COMPLETED Phase PHASE4
NCT03034187 Radiation-induced Toxicity in Prostate Cancer/ Standard-Follow-Up Program Prostate Status RECRUITING Phase N/A
NCT03031821 Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome Status TERMINATED Phase PHASE3
NCT03031613 Effects of PEEP on Intracranial and Intraocular Pressure in Robot-assisted Laparoscopic Radical Prostatectomy Status UNKNOWN Phase NA
NCT03030885 Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Status COMPLETED Phase PHASE1
NCT03029533 Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate Cancer Status UNKNOWN Phase PHASE1